FRAS1
Basic information
Region (hg38): 4:78057323-78544269
Links
Phenotypes
GenCC
Source:
- Fraser syndrome 1 (Definitive), mode of inheritance: AR
- Fraser syndrome (Supportive), mode of inheritance: AR
- renal agenesis, unilateral (Supportive), mode of inheritance: AD
- Fraser syndrome 1 (Strong), mode of inheritance: AR
- Fraser syndrome (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Fraser syndrome 1 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic; Renal | 12766769; 16894541; 17163535; 18671281; 22029163 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (119 variants)
- Fraser syndrome 1 (37 variants)
- Renal agenesis (3 variants)
- FRAS1-related disorder (3 variants)
- Congenital anomaly of kidney and urinary tract (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FRAS1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 21 | 846 | 38 | 905 | ||
missense | 548 | 39 | 37 | 626 | ||
nonsense | 58 | 17 | 77 | |||
start loss | 0 | |||||
frameshift | 80 | 91 | ||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 45 | 53 | ||||
splice region | 2 | 4 | 19 | 120 | 13 | 158 |
non coding | 63 | 451 | 61 | 575 | ||
Total | 143 | 73 | 639 | 1338 | 136 |
Highest pathogenic variant AF is 0.0000461
Variants in FRAS1
This is a list of pathogenic ClinVar variants found in the FRAS1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-78057588-C-G | Fraser syndrome 1 | Uncertain significance (Jan 12, 2018) | ||
4-78057753-G-T | Fraser syndrome 1 | Benign (Jan 12, 2018) | ||
4-78057765-C-G | Fraser syndrome 1 | Uncertain significance (Jan 13, 2018) | ||
4-78057777-A-T | Fraser syndrome 1 | Uncertain significance (Jan 12, 2018) | ||
4-78057822-C-T | Fraser syndrome 1 | Uncertain significance (Jan 13, 2018) | ||
4-78057825-G-T | Fraser syndrome 1 | Uncertain significance (Jan 13, 2018) | ||
4-78057945-T-C | Fraser syndrome 1 | Benign (Jan 12, 2018) | ||
4-78057987-C-T | Fraser syndrome 1 | Benign (Jan 13, 2018) | ||
4-78057992-G-T | Fraser syndrome 1 | Uncertain significance (Jul 07, 2021) | ||
4-78058022-A-T | Fraser syndrome 1 | Pathogenic/Likely pathogenic (Nov 04, 2023) | ||
4-78058023-A-T | Uncertain significance (Jul 28, 2023) | |||
4-78058025-G-A | Inborn genetic diseases | Uncertain significance (Dec 27, 2023) | ||
4-78058027-G-A | Likely benign (Jan 17, 2024) | |||
4-78058033-C-T | Likely benign (Jan 20, 2024) | |||
4-78058036-G-A | Likely benign (Oct 06, 2023) | |||
4-78058038-T-C | Uncertain significance (Jun 24, 2022) | |||
4-78058039-G-A | Likely benign (Nov 22, 2023) | |||
4-78058048-G-A | FRAS1-related disorder | Conflicting classifications of pathogenicity (Jan 27, 2024) | ||
4-78058048-G-T | Likely benign (Dec 30, 2023) | |||
4-78058054-G-T | Likely benign (Oct 22, 2023) | |||
4-78058056-A-C | Fraser syndrome 1 | Uncertain significance (Dec 02, 2023) | ||
4-78058080-C-A | Uncertain significance (May 06, 2015) | |||
4-78058081-C-T | Likely benign (Feb 04, 2023) | |||
4-78058086-G-A | Likely pathogenic (Mar 04, 2023) | |||
4-78058090-G-A | Fraser syndrome 1 | Uncertain significance (Jan 12, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FRAS1 | protein_coding | protein_coding | ENST00000264895 | 74 | 486700 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.08e-45 | 1.00 | 124417 | 1 | 287 | 124705 | 0.00116 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0780 | 2137 | 2.15e+3 | 0.995 | 0.000117 | 26340 |
Missense in Polyphen | 533 | 620.43 | 0.85908 | 7652 | ||
Synonymous | -0.338 | 846 | 834 | 1.01 | 0.0000479 | 7670 |
Loss of Function | 5.58 | 104 | 186 | 0.559 | 0.00000959 | 2301 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00222 | 0.00220 |
Ashkenazi Jewish | 0.000604 | 0.000596 |
East Asian | 0.00186 | 0.00184 |
Finnish | 0.000419 | 0.000418 |
European (Non-Finnish) | 0.00131 | 0.00129 |
Middle Eastern | 0.00186 | 0.00184 |
South Asian | 0.00131 | 0.00124 |
Other | 0.000497 | 0.000495 |
dbNSFP
Source:
- Disease
- DISEASE: Fraser syndrome 1 (FRASRS1) [MIM:219000]: A form of Fraser syndrome, an autosomal recessive disorder characterized by cryptophthalmos, cutaneous syndactyly, and urogenital abnormalities including renal agenesis or hypoplasia. Additional features include abnormalities of the larynx, ear malformations, and facial abnormalities. {ECO:0000269|PubMed:12766769, ECO:0000269|PubMed:23473829}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.109
Intolerance Scores
- loftool
- 0.806
- rvis_EVS
- 4.65
- rvis_percentile_EVS
- 99.77
Haploinsufficiency Scores
- pHI
- 0.593
- hipred
- Y
- hipred_score
- 0.544
- ghis
- 0.412
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0989
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Fras1
- Phenotype
- growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; cellular phenotype; skeleton phenotype; renal/urinary system phenotype; respiratory system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype; limbs/digits/tail phenotype; vision/eye phenotype;
Zebrafish Information Network
- Gene name
- fras1
- Affected structure
- pharyngeal arch cartilage
- Phenotype tag
- abnormal
- Phenotype quality
- morphology
Gene ontology
- Biological process
- morphogenesis of an epithelium;metanephros morphogenesis;cell communication;protein transport;embryonic limb morphogenesis;skin development;roof of mouth development
- Cellular component
- basement membrane;plasma membrane;integral component of membrane;collagen-containing extracellular matrix
- Molecular function
- extracellular matrix structural constituent;metal ion binding